Skip to main content
Vivoryon Therapeutics N.V. (FRA:05Y)
Germany flag Germany · Delayed Price · Currency is EUR
1.596
+0.028 (1.79%)
At close: Dec 5, 2025

Vivoryon Therapeutics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-12.48-20.57-28.34-28.16-12.66-16.51
Upgrade
Depreciation & Amortization
0.150.150.170.160.170.15
Upgrade
Loss (Gain) From Sale of Investments
---0.010.08-
Upgrade
Stock-Based Compensation
1.712.183.943.491.760.16
Upgrade
Provision & Write-off of Bad Debts
---0.04-0.050.1-
Upgrade
Other Operating Activities
0.730.772.971.73-0.130.51
Upgrade
Change in Accounts Payable
-0.46-1.90.54-1.723.450.37
Upgrade
Change in Other Net Operating Assets
-0.010.2-0.772.76-4.031.31
Upgrade
Operating Cash Flow
-10.37-19.17-21.54-21.79-11.26-14.01
Upgrade
Capital Expenditures
-0.01-0-0.01-0.01-0.02-0.06
Upgrade
Sale (Purchase) of Intangibles
---0.5-0-0.01-0.58
Upgrade
Investment in Securities
-10-10---
Upgrade
Investing Cash Flow
-0.0110-10.51-0.01-0.03-0.64
Upgrade
Long-Term Debt Repaid
--0.06-0.09-0.09-0.09-0.09
Upgrade
Net Debt Issued (Repaid)
-0.06-0.06-0.09-0.09-0.09-0.09
Upgrade
Issuance of Common Stock
0-26.35361.14-
Upgrade
Other Financing Activities
---2.1-2.53-1.88-
Upgrade
Financing Cash Flow
-0.06-0.0624.1633.38-0.83-0.09
Upgrade
Foreign Exchange Rate Adjustments
-00.04-0.10.320.47-0.48
Upgrade
Net Cash Flow
-10.44-9.2-7.9911.89-11.65-15.22
Upgrade
Free Cash Flow
-10.38-19.18-21.56-21.81-11.28-14.08
Upgrade
Free Cash Flow Margin
-----104.77%-
Upgrade
Free Cash Flow Per Share
-0.40-0.74-0.85-0.99-0.56-0.70
Upgrade
Cash Interest Paid
00000.010.01
Upgrade
Levered Free Cash Flow
-6.2-12.06-11.59-14.93-5.47-8.58
Upgrade
Unlevered Free Cash Flow
-6.17-12.03-11.55-14.91-5.46-8.58
Upgrade
Change in Working Capital
-0.47-1.7-0.241.03-0.581.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.